In a report released today, Yaron Werber from TD Cowen maintained a Buy rating on Septerna, Inc. (SEPN – Research Report). The company’s shares ...

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Get Free Report) saw unusually large options trading activity on Friday. Traders acquired 12,381 call options on the stock. This represents an increase of ...

Financial giants have made a conspicuous bearish move on SpringWorks Therapeutics. Our analysis of options history for ...

Shares of SpringWorks Therapeutics SWTX have rallied 32.9% in the past three months compared with the industry’s increase of 2.7%. Here, we discuss the reasons for the same. Strong Launch of SWTX's ...

SpringWorks Therapeutics (SWTX) saw the biggest retail follower increase among biotech stocks last week on Stocktwits, even as its shares tumbled more than 14%, marking their worst weekly decline ...

The FDA has approved SpringWorks Therapeutics’s mirdametinib (Gomekli) for adult and paediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic ...

Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the application of a medicine approach to acquiring, developing, and commercializing medicines.

Financial giants have made a conspicuous bearish move on SpringWorks Therapeutics. Our analysis of options history for SpringWorks Therapeutics SWTX revealed 9 unusual trades. Delving into the ...

Barclays analyst Peter Lawson says SpringWorks Therapeutics (SWTX) this morning cancelled from the firm’s conference next week, following cancellations from other public events since the ...

根据监管文件显示，SpringWorks Therapeutics, Inc.（NASDAQ:SWTX）首席运营官Edris Badreddin于2025年3月3日出售了大量公司普通股。Badreddin ...